Our Approach

Acorn Technologies works with a range of players and participants within the life sciences sector, and takes on projects at various stages of the innovation chain – from concept through to commercialisation. The scope of Acorn Technologies’ involvement in transforming inventions into innovations is depicted in the schematic below.

Click for larger version

Acorn Technologies has built a team and a network with the requisite mix of commercial and technical know-how that understands the complexities of projects in the life sciences sector, and to add value to each project. The four broad performance areas Acorn Technologies focuses on to be a successful incubator, are

Building relationships: The life sciences sector in South Africa is a small one, and it is appropriate that an environment of collaboration exists. Acorn Technologies has built good relationships with the various ‘feeder’ sources of novel concepts/technologies that hold promising commercialisation value, viz. the Higher Tertiary Education institutions (HTEs), existing SMMEs, entrepreneurs, and funders/investors, and the majority of Acorn Technologies’ projects arrive through these channels.  Also, Acorn Technologies operates within a highly networked environment, and is able to bring on board an array of commercial and technical experts to add specialist value to its projects, where and when required.

Identifying the right projects: The timescales involved in life science projects are extended, and it is therefore crucial to select the winners.  Before accepting a project into its portfolio, Acorn Technologies project managers will subject the opportunity to a series of in-house screening and evaluation techniques (due diligence), to determine its worth as an investment opportunity, its fit with the rest of the portfolio, and the level of match with Acorn Technologies’ mandate.  A full risk assessment will also be performed on the project.

Developing projects: It is Acorn Technologies’ role to actively develop projects, increasing their commercial value and removing risk elements. There are four broad areas (each with sub-areas) representing the commercialisation drivers of a project, and each project will be constantly evaluated against these to track changes in the project’s value and its risk profile. The four areas are: (i) the market opportunity, and the potential for revenue and profit generation, (ii) the strength of the underlying technology or technical uniqueness of the project, which should form the basis of the venture’s competitive advantage, (iii) the business itself, including the strength of the team and the business- and revenue models, and (iv) the level of strategic fit, within the context of Acorn Technologies’ existing projects and existing research and/or commercial activity in the same area.

Embarking on industry-wide initiatives: Acorn Technologies recognises that there are broader issues that affect the competitiveness and growth of the local life sciences sector. Therefore a holistic approach to our involvement in the sector is preferable and accordingly have launched various initiatives aimed at addressing ‘problem areas’ in the sector.